Armistice Capital, LLC Sangamo Therapeutics, Inc Transaction History
Armistice Capital, LLC
- $7.34 Billion
- Q1 2024
A detailed history of Armistice Capital, LLC transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Armistice Capital, LLC holds 16,958,477 shares of SGMO stock, worth $7.63 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
16,958,477Holding current value
$7.63 Million% of portfolio
0.15%Shares
1 transactions
Others Institutions Holding SGMO
# of Institutions
138Shares Held
100MCall Options Held
35.5KPut Options Held
65.8K-
Wasatch Advisors Inc Salt Lake City, UT20.1MShares$9.06 Million0.07% of portfolio
-
Black Rock Inc. New York, NY13.3MShares$5.97 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$5.49 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA4.94MShares$2.22 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.36MShares$1.51 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $70.4M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...